Pharmaceutical

STAT+: David Liu startup to focus on getting CRISPR the...

A startup by prominent biochemist David Liu seeks to turn hollowed out viruses i...

STAT+: Johnson & Johnson is getting rid of its script l...

Johnson & Johnson will replace the well-known signature script in its logo with ...

STAT+: South Africa investigates Johnson & Johnson over...

South African authorities are investigating Johnson & Johnson and its Janssen su...

STAT+: Chamber of Commerce, government clash at first c...

The Chamber of Commerce and the federal government sparred in court over whether...

STAT+: Dana-Farber deal highlights a surprising trend: ...

Medical care is moving outpatient, yet Dana-Farber and others are building new c...

STAT+: Dana-Farber blindsided Brigham and Women’s. The ...

It’s Boston’s biggest divorce since Gisele and Tom split, but this one is epical...

STAT+: Pharmalittle: House panel inches into fixing dru...

A House committee took a first step toward legislation to fix hospital drug shor...

Opinion: The morally ground-shifting legacy of Ian Wilm...

Ian Wilmut, the British scientist behind the first-ever cloning of a mammal, die...

Opinion: How the Wegovy shortage is making life impossi...

Medical weight management has become an endurance sport for one doctor and her p...

Randomized controlled trials are the ‘gold standard’ of...

“Maybe the larger question is, would anything be enough? For certain audiences, ...

Polio transmission was supposed to end by 2023. A new r...

In 2023 alone, there have been as many as 240 children in a couple of dozen coun...

Signal: Danaher’s $5.7bn acquisition of Abcam faces sta...

Abcam founder Jonathan Milner has declared his intention to vote against the acq...

Cure Genetics and Frametact seek gene cures for neurolo...

Cure Genetics has entered a partnership and licensing deal with Frametact to dev...

Market cap rebound by top 20 biopharmaceutical companie...

Market capitalisation increased by a total of 2.3% from $3.49tn in Q1 2023 to $3...

Generate:Biomedicines secures $273m to advance therapeu...

Generate:Biomedicines has secured $273m in Series C financing round to expedite ...

No more cookies: How healthcare companies can gain trus...

Healthcare and life sciences companies have long relied on third-party cookies f...